Medicines Australia Chief Executive Officer, Tim James resigned from his role as head of the pharmaceutical lobby group over the weekend, following a public clash with Federal Health Minister, The Hon. Sussan Ley MP.

According to a report published by Fairfax Media on Saturday, December 19, 2015, Mr James allegedly stepped down mainly due to failed negotiations involving a five-year “strategic agreement” between the Federal Government and Medicines Australia, “which would have provided greater certainty for the local industry”, but fell through in June 2015.

In a statement announcing his resignation, released on Saturday, December 19, Mr James said, “It has been a tremendous honour and privilege to lead this innovative industry in Australia.

“I’m looking forward to spending time in Sydney with my young family, to whom I owe so much after this year.”

Despite his conservative political background, Mr James and other members of MA came to loggerheads with the Federal Government throughout 2015 due to cuts to the Pharmaceutical Benefits Scheme (PBS).

Mr James’ resignation comes just two-months after former MA Chair, Martin Cross, retired from his position.

According to SBS reports, interim Chairman, Wes Cook, thanked Mr James for his work and explained MA’s Board will be looking to appoint a new CEO in 2016.